[Epidemiological and Pathological Features of Cancer in Fez Boulemane Region, Morocco]
Overview
Affiliations
In Fez-Boulemane, Morocco, there is no cancer registry so there is a lack of information about the incidence and characteristics of cancer in the region. In this retrospective study we examined the epidemiological and pathological features of 5532 cases of cancer collected from the Department of Pathology in Hassan II University Hospital of Fes from 2004 to 2010. The mean age of the patients was 53.5 years and 52% were male. Digestive cancers and skin cancers were the most common. Digestive cancers were predominantly colorectal and stomach. Cancers of the urinary bladder and colorectal cancers were the leading cancers in men accounting respectively for 9% and 8% of all male cancers. In women, cancers of the breast (62%) and uterine cervix (22.6%) predominated. As a first step in cancer control in our area, establishment of a regional cancer registry is recommended.
Proportion of thyroid cancer and other cancers in the democratic republic of Congo.
Bukasa-Kakamba J, Bangolo A, Bayauli P, Mbunga B, Iyese F, Nkodila A World J Exp Med. 2023; 13(3):17-27.
PMID: 37396884 PMC: 10308319. DOI: 10.5493/wjem.v13.i3.17.
Bourakkadi Idrissi M, El Bouhaddouti H, Mouaqit O, Ousadden A, Ait Taleb K, Benjelloun E Cureus. 2023; 15(4):e37563.
PMID: 37193477 PMC: 10183151. DOI: 10.7759/cureus.37563.
Gastric Signet Ring Cell Carcinoma: A Comparative Analysis of Clinicopathologic Features.
Efared B, Kadi M, Tahiri L, Lahmidani N, Hassani K, El Bouhaddouti H Cancer Control. 2020; 27(1):1073274820976596.
PMID: 33269609 PMC: 8480344. DOI: 10.1177/1073274820976596.
Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis.
Adeloye D, Sowunmi O, Jacobs W, David R, Adeosun A, Amuta A J Glob Health. 2018; 8(1):010419.
PMID: 29740502 PMC: 5903682. DOI: 10.7189/jogh.08.010419.
Cancer incidence in eastern Morocco: cancer patterns and incidence trends, 2005-2012.
Elidrissi Errahhali M, Elidrissi Errahhali M, Ouarzane M, Boulouiz R, Bellaoui M BMC Cancer. 2017; 17(1):587.
PMID: 28851324 PMC: 5575884. DOI: 10.1186/s12885-017-3597-6.